The Case | Membranous nephropathy after alemtuzumab treatment

Kidney Int. 2021 Jul;100(1):249-250. doi: 10.1016/j.kint.2021.02.030.
No abstract available

MeSH terms

  • Alemtuzumab / adverse effects
  • Glomerulonephritis, Membranous* / chemically induced
  • Glomerulonephritis, Membranous* / diagnosis
  • Glomerulonephritis, Membranous* / drug therapy
  • Humans

Substances

  • Alemtuzumab